Ultra-Sensitive High-Resolution Profiling of Anti-SARS-CoV-2 Antibodies for Detecting Early Seroconversion in COVID-19 Patients

Name: Ultra-Sensitive High-Resolution Profiling of Anti-SARS-CoV-2 Antibodies for Detecting Early Seroconversion in COVID-19 Patients
Creator: Tal Gilboa
Published: 2020-07-14T23:13:51.872Z
Keywords: Infectious Disease Serology, Biomedical Sensor

Gilboa, Tal; Norman, Maia; Ogata, Alana F.; Maley, Adam M.; Cohen, Limor; Busch, Evan L.; Lazarovits, Roey; Mao, Chih-Ping; Cai, Yongfei; Zhang, Jun; Feldman, Jared E.; Hauser, Blake M.; Caradonna, Timothy M.; Chen, Bing; Schmidt, Aaron G.; Alter, Galit; Charles, Richelle C.; Ryan, Edward T.; Walt, David R.

doi:10.17632/2f73pzdkr4.1

Ultra-Sensitive High-Resolution Profiling of Anti-SARS-CoV-2 Antibodies for Detecting Early Seroconversion in COVID-19 Patients

Published: 14 July 2020| Version 1 | DOI: 10.17632/2f73pzdkr4.1

Contributors:

, Maia Norman, Alana F. Ogata, Adam M. Maley, Limor Cohen, Evan L. Busch, Roey Lazarovits, Chih-Ping Mao, Yongfei Cai, Jun Zhang, Jared E. Feldman, Blake M. Hauser, Timothy M. Caradonna, Bing Chen, Aaron G. Schmidt, Galit Alter, Richelle C. Charles, Edward T. Ryan, David R. Walt

Description

This data was used for the figures presented in the text and SI. Data_DiscoveryCohort: SI figure 5 Data_TrainingCohort: Main text, figure 2 Data_ValidationCohort: Main text, figure 4

Files

Institutions

Brigham and Women's Hospital, Harvard University Wyss Institute for Biologically Inspired Engineering, Harvard Medical School

Ultra-Sensitive High-Resolution Profiling of Anti-SARS-CoV-2 Antibodies for Detecting Early Seroconversion in COVID-19 Patients

Description

Files

Institutions

Categories

Licence